サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541104

呼吸器合胞体ウイルス診断薬市場レポート：製品、最終用途、地域別 2024-2032

Respiratory Syncytial Virus Diagnostics Market Report by Product, End Use, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 135 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=141.77円
呼吸器合胞体ウイルス診断薬市場レポート：製品、最終用途、地域別 2024-2032
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の呼吸器合胞体ウイルス（RSV）診断薬市場規模は、2023年に10億520万米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけての成長率（CAGR）は8.1％を示し、2032年には20億7,230万米ドルに達すると予測しています。

呼吸器合胞体ウイルス（RSV）は、肺と呼吸器のウイルス感染症で、喘息、入院、肺炎、反復感染、中耳炎、死亡の原因となります。血液検査、胸部X線検査、分泌物のぬぐい取り検査、パルスオキシメトリーなどを用いて、肺の炎症、白血球数、血中酸素濃度などの徴候を確認することで診断できます。RSVの一般的な治療法としては、市販薬、点滴、加湿酸素、人工呼吸、吸入気管支拡張薬などがあります。

呼吸器合胞体ウイルス（RSV）診断薬の市場動向：

RSV感染症は、2歳未満の小児が重篤な呼吸器症状を発症する傾向があるため、新生児期に深刻化する可能性があります。このことは、子どもの医療に対する親の関心の高まりと相まって、市場の成長を促進する重要な要因の1つとなっています。さらに、早期診断後の生存率の高さや、診断手段の入手のしやすさも成長を促す要因となっています。これとは別に、ヘルスケアインフラの改善や入院乳幼児の治療に対する有利な償還政策も市場成長に寄与しています。さらに、バイオテクノロジーやナノテクノロジーのような先端技術の出現は、ウェスタンブロット、酵素結合免疫吸着測定法（ELISA）、直接免疫蛍光法、リアルタイムポリメラーゼ連鎖反応（PCR）のような、RSVの最新検出システムの開発を促進しています。このほか、各国の政府機関が新しい治療薬の開発のための研究開発（R&D）プロジェクトに資金を提供しています。市場を牽引すると予測されるその他の要因としては、臨床ワクチン試験の増加、体外診断薬に対する需要の高まり、小児肺炎の発生率の上昇、分子診断薬の採用増加などが挙げられます。

本レポートで扱う主な質問

  • 世界の呼吸器合胞体ウイルス（RSV）診断薬市場はこれまでどのように推移してきたか？
  • COVID-19が世界の呼吸器合胞体ウイルス（RSV）診断薬市場に与えた影響は？
  • 主要な地域市場は？
  • 製品別の市場内訳は？
  • 最終用途別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の呼吸器合胞体ウイルス（RSV）診断薬市場の構造と主要企業は？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界呼吸器合胞体ウイルス（RSV）診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 直接蛍光抗体法（DFA）
    • 市場動向
    • 市場予測
  • 迅速抗原診断検査（RADT）
    • 市場動向
    • 市場予測
  • 分子診断
    • 市場動向
    • 市場予測
  • クロマトグラフィー免疫測定法
    • 市場動向
    • 市場予測
  • 診断画像
    • 市場動向
    • 市場予測
  • ゲルマイクロドロップレット
    • 市場動向
    • 市場予測
  • フローサイトメトリー
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：最終用途別

  • 病院と診療所
    • 市場動向
    • 市場予測
  • 研究室
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Coris BioConcept
    • DiaSorin Molecular LLC（DiaSorin Inc）
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Quest Diagnostics Incorporated
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Respiratory Syncytial Virus Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by End Use (in %), 2023
  • Figure 6: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: North America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: North America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: United States: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: United States: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Canada: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Canada: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: China: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: China: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Japan: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Japan: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: India: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: India: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: South Korea: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: South Korea: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Australia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Australia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Indonesia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Indonesia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Europe: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Europe: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Germany: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Germany: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: France: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: France: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: United Kingdom: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: United Kingdom: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Italy: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Italy: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Spain: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Spain: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Russia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Russia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Latin America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Latin America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Brazil: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Brazil: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Mexico: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Mexico: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 77: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Global: Respiratory Syncytial Virus Diagnostics Industry: SWOT Analysis
  • Figure 79: Global: Respiratory Syncytial Virus Diagnostics Industry: Value Chain Analysis
  • Figure 80: Global: Respiratory Syncytial Virus Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Respiratory Syncytial Virus Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 4: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Respiratory Syncytial Virus Diagnostics Market: Competitive Structure
  • Table 6: Global: Respiratory Syncytial Virus Diagnostics Market: Key Players
目次
Product Code: SR112024A4048

The global respiratory syncytial virus (RSV) diagnostics market size reached US$ 1,005.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,072.3 Million by 2032 exhibiting a growth rate (CAGR) of 8.1% during 2024-2032.

Respiratory syncytial virus (RSV) is a viral infection of the lungs and respiratory tract, which can cause asthma, hospitalization, pneumonia, repeated infections, middle ear infection, and death. It can be diagnosed using blood tests, chest x-rays, a swab of secretions, and pulse oximetry by checking for signs like lung inflammation, white blood cell (WBC) count, and oxygen levels in the blood. Some of the commonly available treatment options for RSV are over-the-counter (OTC) medications, intravenous (IV) fluids, humidified oxygen, mechanical ventilation, and inhaled bronchodilators.

Respiratory Syncytial Virus (RSV) Diagnostics Market Trends:

RSV infection can be more serious during the neonatal period as children under two years of age tend to develop severe respiratory symptoms. This, in confluence with the rising focus of parents on child medical care, represents one of the crucial factors fostering the growth of the market. Moreover, the high survival rates after early diagnosis and the easy availability of diagnostic modalities act as other growth-inducing factors. Apart from this, the improving healthcare infrastructure and favorable reimbursement policies for the treatment of hospitalized infants are also contributing to market growth. Furthermore, the advent of advanced techniques like bio- and nanotechnology is facilitating the development of modern detection systems for RSV, such as western blot, enzyme-linked immunosorbent assay (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). Besides this, governing agencies of numerous countries are funding research and development (R&D) projects for the development of new therapeutics. Other factors projected to drive the market are the growing number of clinical vaccine trials, the escalating demand for in-vitro diagnostics, rising incidences of childhood pneumonia and the increasing adoption of molecular diagnostics.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory syncytial virus (RSV) diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and end use.

Breakup by Product:

Direct Fluorescent Antibody (DFA) Method

Rapid Antigen Diagnostic Test (RADTs)

Molecular Diagnostics

Chromatographic Immunoassay

Diagnostic Imaging

Gel Microdroplets

Flow Cytometry

Others

Breakup by End Use:

Hospitals and Clinics

Laboratory

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Coris BioConcept, DiaSorin Molecular LLC (DiaSorin Inc), F. Hoffmann-La Roche AG, Merck KGaA, Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global respiratory syncytial virus (RSV) diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global respiratory syncytial virus (RSV) diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global respiratory syncytial virus (RSV) diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Direct Fluorescent Antibody (DFA) Method
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Rapid Antigen Diagnostic Test (RADTs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Molecular Diagnostics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Chromatographic Immunoassay
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Diagnostic Imaging
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Gel Microdroplets
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Flow Cytometry
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by End Use

  • 7.1 Hospitals and Clinics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Laboratory
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Becton, Dickinson and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 bioMerieux SA
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bio-Rad Laboratories Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Coris BioConcept
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 DiaSorin Molecular LLC (DiaSorin Inc)
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 F. Hoffmann-La Roche AG
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 SWOT Analysis
    • 13.3.8 Merck KGaA
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Quest Diagnostics Incorporated
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Quidel Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Thermo Fisher Scientific Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis